hematoxylin has been researched along with casein kinase ii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, PJ; Hung, MS; Jablons, DM; Lin, YC; Mao, JH; Xu, Z; Yang, CT; You, L | 1 |
| Chen, Y; Hsieh, D; Hung, MS; Jablons, DM; Lin, YC; Mao, JH; Smith, E; Xu, Z; Yang, CT; You, L | 1 |
| Adami, V; Astolfi, A; Barreca, ML; Biasini, E; Biggi, S; Bonetto, V; Dalle Vedove, A; Gatto, P; Lolli, G; Luotti, S; Massignan, T; Pancher, M; Stincardini, C | 1 |
3 other study(ies) available for hematoxylin and casein kinase ii
| Article | Year |
|---|---|
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
Topics: Adenosine Triphosphate; Apoptosis; Casein Kinase II; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; HCT116 Cells; HeLa Cells; Hematoxylin; Humans; Lung Neoplasms; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Substrate Specificity | 2009 |
Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.
Topics: Animals; Apoptosis; Blotting, Western; Casein Kinase II; Enzyme Inhibitors; Female; Hematoxylin; Humans; Immunoenzyme Techniques; Lung Neoplasms; Mice; Mice, Inbred BALB C; Phosphorylation; Proto-Oncogene Proteins c-akt; T Cell Transcription Factor 1; Tumor Cells, Cultured; Wnt Proteins; Xenograft Model Antitumor Assays | 2013 |
Identification of compounds inhibiting prion replication and toxicity by removing PrP
Topics: Animals; Casein Kinase II; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Evaluation, Preclinical; Fluorescent Dyes; Gene Expression; Green Fluorescent Proteins; Harmaline; HEK293 Cells; Hematoxylin; Humans; Mice; Neuroblastoma; Prions; PrPC Proteins; Quinacrine; Tacrolimus | 2020 |